Toll-like receptors in central nervous system glial inflammation and homeostasis - PubMed (original) (raw)
Review
Toll-like receptors in central nervous system glial inflammation and homeostasis
Tammy Kielian. J Neurosci Res. 2006 Apr.
Abstract
Toll-like receptors (TLRs) are a family of pattern-recognition receptors expressed on cells of the innate immune system that allow for the recognition of conserved structural motifs on a wide array of pathogens, referred to as pathogen-associated molecular patterns, as well as some endogenous molecules. The recent emergence of studies examining TLRs in the central nervous system (CNS) indicates that these receptors not only play a role in innate immunity in response to infectious diseases but may also participate in CNS autoimmunity, neurodegeneration, and tissue injury. This review summarizes the experimental evidence demonstrating a role for TLRs in the context of CNS inflammation in both infectious and noninfectious conditions.
Figures
Fig. 1
Signaling cascades initiated via TLR2- and TLR4-dependent activation. Engagement of TLR2 on the cell surface as a heterodimer with either TLR1 or TLR6 leads to the recruitment of the adaptor protein MyD88 and interaction with TIR-domain-containing adaptor protein (TIRAP) via death-domain interactions. Subsequently, IL-1-receptor-associated kinase (IRAK) and tumor necrosis factor-associated factor 6 (TRAF6) are recruited, leading to the phosphorylation and degradation of inhibitory-κB (IκB), allowing the nuclear translocation of NF-κB and subsequent induction of target genes such as tumor necrosis factor-α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1/CCL2). The adaptor molecule MD-2 is involved in TLR4-mediated activation, which can lead to the recruitment of either of two adaptor proteins: the MyD88-dependent pathway occurs as described for TLR2; however, an alternative pathway has recently been identified. Upon TLR4 activation, the adaptor protein TRIF-related adaptor molecule (TRAM) can be activated, which associates with TIR-domain-containing adaptor-inducing IFN-β (TRIF). This complex activates IKKε and interacts with TBK-1 to induce translocation of the IFN-inducible transcription factor interferon response factor-3 (IRF-3) to the nucleus, where it transcriptionally activates IFN-inducible genes, such as IFN-β and IFN-inducible protein of 10 kDa (IP-10). Figure adapted from Microbes and Infection, Vol. 6, Kaisho T. and Akira S., Pleiotropic function of Toll-like receptors, p. 1388–1394, 2004, with permission from Elsevier.
Fig. 2
Potential roles of TLRs in the CNS response to infection and injury. Microglia and astrocytes respond to numerous PAMPs, including peptidoglycan (PGN; TLR2 agonist), double-stranded RNA (dsRNA; TLR3 agonist), lipopolysaccharide (LPS; TLR4 agonist), and unmethylated CpG oligodeoxynucleotides and/or bacterial DNA (CpG DNA; TLR9 agonist). The resultant effect of glial PAMP stimulation is the elaboration of a wide array of proinflammatory cytokines (including TNF-α, IL-1β, and IL-12), chemokines [including macrophage inflammatory protein-2 (MIP-2/CXCL2) and monocyte chemoattractant protein-1 (MCP-1)], and reactive oxygen/nitrogen species [ROI/RNI; including superoxide (O2−) and nitric oxide (NO)]. These proinflammatory mediators contribute to enhanced blood–brain barrier (BBB) permeability and the resultant influx of peripheral immune cells into the CNS parenchyma, the extent of which is dictated by the nature of the proinflammatory milieu. Endogenous TLR ligands may be released from injured cells within the CNS parenchyma that may serve to augment neuroinflammation further; however, their role in TLR-dependent glial activation remains to be determined. The outcome of this neuroinflammatory response (i.e., beneficial vs. detrimental) is unclear and likely depends on the context of the insult and duration of inflammation. (Figure adapted from Kielian, 2004a.)
Similar articles
- Toll-like receptors in the CNS: implications for neurodegeneration and repair.
van Noort JM, Bsibsi M. van Noort JM, et al. Prog Brain Res. 2009;175:139-48. doi: 10.1016/S0079-6123(09)17509-X. Prog Brain Res. 2009. PMID: 19660653 Review. - Toll-like receptors are key players in neurodegeneration.
Arroyo DS, Soria JA, Gaviglio EA, Rodriguez-Galan MC, Iribarren P. Arroyo DS, et al. Int Immunopharmacol. 2011 Oct;11(10):1415-21. doi: 10.1016/j.intimp.2011.05.006. Epub 2011 May 25. Int Immunopharmacol. 2011. PMID: 21616174 Free PMC article. Review. - Glial toll-like receptor signaling in central nervous system infection and autoimmunity.
Carpentier PA, Duncan DS, Miller SD. Carpentier PA, et al. Brain Behav Immun. 2008 Feb;22(2):140-7. doi: 10.1016/j.bbi.2007.08.011. Epub 2007 Oct 24. Brain Behav Immun. 2008. PMID: 17920811 Free PMC article. Review. - Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases.
Li L, Acioglu C, Heary RF, Elkabes S. Li L, et al. Brain Behav Immun. 2021 Jan;91:740-755. doi: 10.1016/j.bbi.2020.10.007. Epub 2020 Oct 8. Brain Behav Immun. 2021. PMID: 33039660 Free PMC article. Review.
Cited by
- TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG.
Zhang ZJ, Guo JS, Li SS, Wu XB, Cao DL, Jiang BC, Jing PB, Bai XQ, Li CH, Wu ZH, Lu Y, Gao YJ. Zhang ZJ, et al. J Exp Med. 2018 Dec 3;215(12):3019-3037. doi: 10.1084/jem.20180800. Epub 2018 Nov 19. J Exp Med. 2018. PMID: 30455267 Free PMC article. - High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy.
Thakur V, Sadanandan J, Chattopadhyay M. Thakur V, et al. Int J Mol Sci. 2020 Jan 30;21(3):881. doi: 10.3390/ijms21030881. Int J Mol Sci. 2020. PMID: 32019145 Free PMC article. - Neuroinflammation and copper in Alzheimer's disease.
Choo XY, Alukaidey L, White AR, Grubman A. Choo XY, et al. Int J Alzheimers Dis. 2013;2013:145345. doi: 10.1155/2013/145345. Epub 2013 Nov 28. Int J Alzheimers Dis. 2013. PMID: 24369524 Free PMC article. Review. - Astroglial TLR9 antagonism promotes chemotaxis and alternative activation of macrophages via modulation of astrocyte-derived signals: implications for spinal cord injury.
Li L, Ni L, Heary RF, Elkabes S. Li L, et al. J Neuroinflammation. 2020 Feb 25;17(1):73. doi: 10.1186/s12974-020-01748-x. J Neuroinflammation. 2020. PMID: 32098620 Free PMC article.
References
- Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 1998;9:143–150. - PubMed
- Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002;71:1–8. - PubMed
- Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499–511. - PubMed
- Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001;413:732–738. - PubMed
- Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science. 1999;285:736–739. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH065297-04/MH/NIMH NIH HHS/United States
- R01 MH065297/MH/NIMH NIH HHS/United States
- R01 NS040730-05/NS/NINDS NIH HHS/United States
- NS-40730/NS/NINDS NIH HHS/United States
- R01 NS040730-06/NS/NINDS NIH HHS/United States
- R01 MH065297-03/MH/NIMH NIH HHS/United States
- P30 NS047546/NS/NINDS NIH HHS/United States
- P30 NS047546-01A1/NS/NINDS NIH HHS/United States
- MH-65297/MH/NIMH NIH HHS/United States
- P30 NS047546-02/NS/NINDS NIH HHS/United States
- R01 NS040730/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources